X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1348) 1348
Newspaper Article (109) 109
Publication (84) 84
Magazine Article (61) 61
Book Review (41) 41
Book Chapter (21) 21
Trade Publication Article (17) 17
Book / eBook (5) 5
Conference Proceeding (3) 3
Newsletter (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (983) 983
laxatives (897) 897
constipation (758) 758
laxatives - therapeutic use (609) 609
index medicus (597) 597
female (522) 522
male (505) 505
constipation - drug therapy (473) 473
aged (292) 292
middle aged (277) 277
adult (259) 259
treatment outcome (222) 222
gastroenterology & hepatology (209) 209
pharmacology & pharmacy (201) 201
cathartics - therapeutic use (186) 186
constipation - therapy (179) 179
care and treatment (173) 173
chronic disease (169) 169
pain (166) 166
child (157) 157
constipation - chemically induced (151) 151
constipation - physiopathology (142) 142
adolescent (140) 140
aged, 80 and over (136) 136
management (134) 134
quality of life (130) 130
narcotics (127) 127
patients (127) 127
analgesics, opioid - adverse effects (126) 126
constipation - etiology (126) 126
double-blind (126) 126
studies (126) 126
animals (122) 122
health aspects (122) 122
pediatrics (121) 121
prevalence (121) 121
clinical trials (120) 120
medicine, general & internal (120) 120
drug therapy (116) 116
research (109) 109
laxative (108) 108
children (107) 107
gastrointestinal agents (107) 107
risk factors (107) 107
constipation - diagnosis (106) 106
palliative care (105) 105
child, preschool (103) 103
polyethylene glycols - therapeutic use (101) 101
cancer (99) 99
quality-of-life (99) 99
efficacy (98) 98
polyethylene glycol (97) 97
colon (96) 96
gastroenterology (95) 95
diarrhea (92) 92
medicine (90) 90
laxatives - adverse effects (88) 88
defecation - drug effects (87) 87
laxatives - administration & dosage (87) 87
pharmaceutical industry (85) 85
usage (85) 85
drug dosages (83) 83
constipation - epidemiology (82) 82
abdomen (81) 81
chronic constipation (79) 79
irritable bowel syndrome (79) 79
analysis (78) 78
young adult (78) 78
medicine & public health (77) 77
adults (73) 73
dosage and administration (73) 73
defecation (72) 72
epidemiology (72) 72
surgery (71) 71
prospective studies (70) 70
retrospective studies (70) 70
safety (70) 70
abridged index medicus (69) 69
irritable-bowel-syndrome (69) 69
lactulose (69) 69
complications and side effects (68) 68
constipation - prevention & control (68) 68
dietary fiber (68) 68
motility (68) 68
research article (67) 67
analgesics (65) 65
nursing (65) 65
dietary fiber - therapeutic use (64) 64
internal medicine (64) 64
double-blind method (63) 63
opioids (63) 63
colonoscopy (62) 62
placebo-controlled trial (62) 62
clinical neurology (61) 61
dose-response relationship, drug (60) 60
rats (60) 60
infant (59) 59
intestine (59) 59
gastrointestinal agents - therapeutic use (58) 58
diet (57) 57
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1445) 1445
German (46) 46
Spanish (15) 15
French (12) 12
Japanese (9) 9
Dutch (7) 7
Korean (7) 7
Danish (4) 4
Russian (3) 3
Italian (2) 2
Latin (2) 2
Swedish (2) 2
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2016, Volume 2016, Issue 8, p. CD009118
Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals... 
CONTROLLED-TRIAL | MAGNESIUM-HYDROXIDE | Dietary Fiber [adverse effects; therapeutic use] | Humans | Child, Preschool | Infant | PSYLLIUM FIBER | Osmosis | Mineral Oil [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Polyethylene Glycols [adverse effects; therapeutic use] | POLYETHYLENE-GLYCOL 3350 | Child | Lactulose [adverse effects; therapeutic use] | HYDROLYZED GUAR GUM | PLUS ELECTROLYTES | Laxatives [adverse effects; therapeutic use] | LIQUID PARAFFIN | Constipation [drug therapy] | Magnesium Hydroxide [adverse effects; therapeutic use] | Randomized Controlled Trials as Topic | Defecation [drug effects; physiology] | CHRONIC FUNCTIONAL CONSTIPATION | Sugar Alcohols [adverse effects; therapeutic use] | Adolescent | DOUBLE-BLIND | RECTAL FECAL IMPACTION | Lactulose - adverse effects | Defecation - drug effects | Polyethylene Glycols - adverse effects | Laxatives - therapeutic use | Magnesium Hydroxide - adverse effects | Polyethylene Glycols - therapeutic use | Sugar Alcohols - therapeutic use | Laxatives - adverse effects | Sugar Alcohols - adverse effects | Magnesium Hydroxide - therapeutic use | Dietary Fiber - therapeutic use | Mineral Oil - adverse effects | Dietary Fiber - adverse effects | Mineral Oil - therapeutic use | Defecation - physiology | Constipation - drug therapy | Lactulose - therapeutic use
Journal Article
1992, ISBN 3805555741, Volume 44, suppl. 1., iii, 52
Book
Journal Article
Biomaterials, ISSN 0142-9612, 2006, Volume 27, Issue 3, pp. 519 - 533
We have previously shown that a novel synthetic hydrogel channel composed of poly(2-hydroxyethyl methacrylate- -methyl methacrylate) (pHEMA-MMA) is... 
Methylcellulose | Neurotrophin-3 | Functional recovery | Fibroblast growth factor-1 | Axonal regeneration | Matrigel | methylcellulose | PERIPHERAL-NERVE REGENERATION | MATERIALS SCIENCE, BIOMATERIALS | axonal regeneration | ENGINEERING, BIOMEDICAL | NEUROTROPHIC FACTOR | fibroblast growth factor-1 | PARAPLEGIC RATS | SCHWANN-CELL GRAFTS | ADULT-RAT | LOCOMOTOR RECOVERY | CORTICOSPINAL TRACT | FIBRIN GLUE | GROWTH-FACTOR | functional recovery | neurotrophin-3 | Matrigel (TM) | Immunohistochemistry | Calcitonin Gene-Related Peptide - analysis | Methylmethacrylates - chemistry | Collagen - chemistry | Polyhydroxyethyl Methacrylate - chemistry | Proteoglycans - chemistry | Fibrin - chemistry | Spinal Cord - chemistry | Spinal Cord - pathology | Guided Tissue Regeneration - methods | Neurofilament Proteins - analysis | Axons - ultrastructure | Female | Methylmethacrylates - therapeutic use | Spinal Cord Injuries - therapy | Nerve Fibers - chemistry | Nerve Fibers - pathology | Myelin Sheath - physiology | Neurotrophin 3 - therapeutic use | Rats | Axons - chemistry | Microscopy, Electron | Rats, Sprague-Dawley | Methylcellulose - chemistry | Proteoglycans - therapeutic use | Animals | Polyhydroxyethyl Methacrylate - therapeutic use | Axons - pathology | Collagen - therapeutic use | Fibroblast Growth Factor 1 - pharmacology | Laminin - therapeutic use | Nerve Regeneration - drug effects | Laminin - chemistry | Fibroblast Growth Factor 1 - therapeutic use | Myelin Sheath - ultrastructure | Spinal Cord - physiopathology | Spinal Cord Injuries - physiopathology | Methylcellulose - therapeutic use | Delayed-Action Preparations | Fibrin - therapeutic use | Hydrogels - therapeutic use | Neurotrophin 3 - pharmacology | Drug Combinations | Hydrogels - chemistry | Fibrin | Polytetrafluoroethylene | Biological products | Collagen | Laxatives | Fibroblast growth factors | Spinal cord injuries | Peptide hormones
Journal Article
Journal Article
Journal Article